{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T09:14:02Z","timestamp":1793783642665,"version":"4.6.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.ymgme.2008.10.017","type":"journal-article","created":{"date-parts":[[2008,12,17]],"date-time":"2008-12-17T09:02:35Z","timestamp":1229504555000},"page":"91-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Long-term inhibition of glycosphingolipid accumulation in Fabry model mice by a single systemic injection of AAV1 vector in the neonatal period"],"prefix":"10.1016","volume":"96","author":[{"given":"Koichi","family":"Ogawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiko","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masamichi","family":"Ishizaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Hanawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Fukunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2008.10.017_bib1","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJM196705252762101","article-title":"Enzymatic defect in Fabry\u2019s disease. Ceramidetrihexosidase deficiency","volume":"276","author":"Brady","year":"1967","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2008.10.017_bib2","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1056\/NEJM199508033330504","article-title":"An atypical variant of Fabry\u2019s disease in men with left ventricular hypertrophy","volume":"333","author":"Nakao","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2008.10.017_bib3","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1073\/pnas.97.1.365","article-title":"Infusion of alpha-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry disease","volume":"97","author":"Schiffmann","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2008.10.017_bib4","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","article-title":"Enzyme replacement therapy in Fabry disease: a randomized controlled trial","volume":"285","author":"Schiffmann","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ymgme.2008.10.017_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","article-title":"Safety and efficacy of recombinant human alpha-galactosidase A\u2014replacement therapy in Fabry\u2019s disease","volume":"345","author":"Eng","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2008.10.017_bib6","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0301-472X(99)00050-8","article-title":"Enzymatic and functional correction along with long-term enzyme secretion from transduced bone marrow hematopoietic stem\/progenitor and stromal cells derived from patients with Fabry disease","volume":"27","author":"Takenaka","year":"1999","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.ymgme.2008.10.017_bib7","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1089\/10430349950017671","article-title":"Correction of enzymatic and lysosomal storage defects in Fabry mice by adenovirus-mediated gene transfer","volume":"10","author":"Ziegler","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymgme.2008.10.017_bib8","doi-asserted-by":"crossref","first-page":"7515","DOI":"10.1073\/pnas.120177997","article-title":"Long-term enzyme correction and lipid reduction in multiple organs of primary and secondary transplanted Fabry mice receiving transduced bone marrow cells","volume":"97","author":"Takenaka","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2008.10.017_bib9","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1073\/pnas.051634498","article-title":"Adeno-associated viral vector-mediated gene transfer results in long-term enzymatic and functional correction in multiple organs of Fabry mice","volume":"98","author":"Jung","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2008.10.017_bib10","doi-asserted-by":"crossref","first-page":"13777","DOI":"10.1073\/pnas.222221899","article-title":"Long-term systemic therapy of Fabry disease in a knockout mouse by adeno-associated virus-mediated muscle-directed gene transfer","volume":"99","author":"Takahashi","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2008.10.017_bib11","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1089\/10430340252939041","article-title":"Correction of the nonlinear dose response improves the viability of adenoviral vectors for gene therapy of Fabry disease","volume":"13","author":"Ziegler","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymgme.2008.10.017_bib12","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1006\/mthe.2002.0605","article-title":"Adenovirus-transduced lung as a portal for delivering alpha-galactosidase A into systemic circulation for Fabry disease","volume":"5","author":"Li","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2008.10.017_bib13","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1073\/pnas.0537900100","article-title":"Long-term correction of globotriaosylceramide storage in Fabry mice by recombinant adeno-associated virus-mediated gene transfer","volume":"100","author":"Park","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2008.10.017_bib14","doi-asserted-by":"crossref","first-page":"16909","DOI":"10.1073\/pnas.0407572101","article-title":"Bioluminescent imaging of a marking transgene and correction of Fabry mice by neonatal injection of recombinant lentiviral vectors","volume":"101","author":"Yoshimitsu","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2008.10.017_bib15","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/jgm.468","article-title":"Partial correction of the alpha-galactosidase A deficiency and reduction of glycolipid storage in Fabry mice using synthetic vectors","volume":"6","author":"Przybylska","year":"2004","journal-title":"J. Gene Med."},{"key":"10.1016\/j.ymgme.2008.10.017_bib16","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ymthe.2003.11.015","article-title":"AAV2 vector harboring a liver-restricted promoter facilitates sustained expression of therapeutic levels of alpha-galactosidase A and the induction of immune tolerance in Fabry mice","volume":"9","author":"Ziegler","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2008.10.017_bib17","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/sj.mt.6300066","article-title":"Correction of the biochemical and functional deficits in Fabry mice following AAV8-mediated hepatic expression of alpha-galactosidase A","volume":"15","author":"Ziegler","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2008.10.017_bib18","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1542\/peds.2005-2895","article-title":"Enzyme-replacement therapy with agalsidase alfa in children with Fabry disease","volume":"118","author":"Ries","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2008.10.017_bib19","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/sj.ki.5000208","article-title":"Clinical benefit of enzyme replacement therapy in Fabry disease","volume":"69","author":"Breunig","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.ymgme.2008.10.017_bib20","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1128\/jvi.61.10.3096-3101.1987","article-title":"A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication","volume":"61","author":"Samulski","year":"1987","journal-title":"J. Virol."},{"key":"10.1016\/j.ymgme.2008.10.017_bib21","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0378-1119(89)90209-6","article-title":"Expression vector system based on the chicken beta-actin promoter directs efficient production of interleukin-5","volume":"79","author":"Miyazaki","year":"1989","journal-title":"Gene"},{"key":"10.1016\/j.ymgme.2008.10.017_bib22","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/sj.mt.6300012","article-title":"AAV1 mediated co-expression of formylglycine-generating enzyme and arylsulfatase A efficiently corrects sulfatide storage in a mouse model of metachromatic leukodystrophy","volume":"15","author":"Kurai","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2008.10.017_bib23","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1038\/sj.mt.6300225","article-title":"Systemic cancer gene therapy using adeno-associated virus type 1 vector expressing MDA-7\/IL24","volume":"15","author":"Tahara","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2008.10.017_bib24","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1073\/pnas.94.6.2540","article-title":"Alpha-galactosidase A deficient mice: a model of Fabry disease","volume":"94","author":"Ohshima","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2008.10.017_bib25","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"A simple method for the isolation and purification of total lipides from animal tissues","volume":"226","author":"Folch","year":"1957","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2008.10.017_bib26","first-page":"2680","article-title":"Distribution of collagen IV in human ocular tissues","volume":"34","author":"Ishizaki","year":"1993","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymgme.2008.10.017_bib27","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0925-4439(98)00012-X","article-title":"Immunohistochemical characterization of transgenic mice highly expressing human lysosomal alpha-galactosidase","volume":"1406","author":"Kase","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2008.10.017_bib28","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1442-200x.2004.01983.x","article-title":"Long-term expressed human alpha-galactosidase A in tissues of HalphaG transgenic mice","volume":"46","author":"Hoshikawa","year":"2004","journal-title":"Pediatr. Int."},{"key":"10.1016\/j.ymgme.2008.10.017_bib29","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.ymthe.2005.04.024","article-title":"Evasion of immune responses to introduced human acid alpha-glucosidase by liver-restricted expression in glycogen storage disease type II","volume":"12","author":"Franco","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2008.10.017_bib30","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1089\/hum.2005.16.68","article-title":"Impact of humoral immune response on distribution and efficacy of recombinant adeno-associated virus-derived acid alpha-glucosidase in a model of glycogen storage disease type II","volume":"16","author":"Cresawn","year":"2005","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymgme.2008.10.017_bib31","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1182\/blood-2004-03-0847","article-title":"Induction of antigen-specific CD4+ T-cell anergy and deletion by in vivo viral gene transfer","volume":"104","author":"Dobrzynski","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2008.10.017_bib32","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1038\/sj.mt.6300219","article-title":"Persistent expression of hF.IX after tolerance induction by in utero or neonatal administration of AAV-1-F.IX in hemophilia B mice","volume":"15","author":"Sabatino","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2008.10.017_bib33","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1038\/sj.gt.3302550","article-title":"Sustained correction of glycogen storage disease type II using adeno-associated virus serotype 1 vectors","volume":"12","author":"Mah","year":"2005","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymgme.2008.10.017_bib34","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/sj.mt.6300100","article-title":"Physiological correction of Pompe disease by systemic delivery of adeno-associated virus serotype 1 vectors","volume":"15","author":"Mah","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2008.10.017_bib35","doi-asserted-by":"crossref","first-page":"17924","DOI":"10.1016\/S0021-9258(17)46793-7","article-title":"Overexpression of human lipoprotein lipase in transgenic mice. Resistance to diet-induced hypertriglyceridemia and hypercholesterolemia","volume":"268","author":"Shimada","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2008.10.017_bib36","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1023\/A:1011006122704","article-title":"A journey to the world of glycobiology","volume":"17","author":"Kobata","year":"2000","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.ymgme.2008.10.017_bib37","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/0003-9861(83)90116-9","article-title":"Organ-specific difference in the sugar chains of gamma-glutamyltranspeptidase","volume":"225","author":"Yamashita","year":"1983","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ymgme.2008.10.017_bib38","first-page":"501","article-title":"Differences in glycosylation pattern of human secretory ribonucleases","volume":"255","author":"Beintema","year":"1988","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymgme.2008.10.017_bib39","doi-asserted-by":"crossref","first-page":"10283","DOI":"10.1016\/S0021-9258(17)44454-1","article-title":"The immunological and structural comparisons of deoxyribonucleases I. Glycosylation differences between bovine pancreatic and parotid deoxyribonucleases","volume":"258","author":"Abe","year":"1983","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2008.10.017_bib40","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1182\/blood-2002-09-2889","article-title":"Sex significantly influences transduction of murine liver by recombinant adeno-associated viral vectors through an androgen-dependent pathway","volume":"102","author":"Davidoff","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2008.10.017_bib41","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/sj.gt.3302262","article-title":"Long-term correction of hyperphenylalaninemia by AAV-mediated gene transfer leads to behavioral recovery in phenylketonuria mice","volume":"11","author":"Mochizuki","year":"2004","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymgme.2008.10.017_bib42","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ymthe.2004.10.004","article-title":"Efficacy of an adeno-associated virus 8-pseudotyped vector in glycogen storage disease type II","volume":"11","author":"Sun","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2008.10.017_bib43","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/ndt\/gfi152","article-title":"Long-term therapy with agalsidase alfa for Fabry disease: safety and effects on renal function in a home infusion setting","volume":"21","author":"Schiffmann","year":"2006","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ymgme.2008.10.017_bib44","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/01.gim.0000237866.70357.c6","article-title":"Fabry disease: guidelines for the evaluation and management of multi-organ system involvement","volume":"8","author":"Eng","year":"2006","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2008.10.017_bib45","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1651-2227.2007.00029.x","article-title":"Enzyme replacement therapy with agalsidase alfa in children with Fabry disease","volume":"96","author":"Ramaswami","year":"2007","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ymgme.2008.10.017_bib46","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2174\/156652307782151434","article-title":"Immunology of neonatal gene transfer","volume":"7","author":"Ponder","year":"2007","journal-title":"Curr. Gene Ther."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719208002679?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719208002679?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:17:46Z","timestamp":1761088666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719208002679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S1096719208002679"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2008.10.017","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term inhibition of glycosphingolipid accumulation in Fabry model mice by a single systemic injection of AAV1 vector in the neonatal period","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2008.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}